Elli Peselev

Array ( [id] => 6896422 [patent_doc_number] => 20010027212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-04 [patent_title] => 'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)' [patent_app_type] => new [patent_app_number] => 09/842976 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6930 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20010027212.pdf [firstpage_image] =>[orig_patent_app_number] => 09842976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7094035 [patent_doc_number] => 20010034434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Process for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A' [patent_app_type] => new [patent_app_number] => 09/740671 [patent_app_country] => US [patent_app_date] => 2001-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2869 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034434.pdf [firstpage_image] =>[orig_patent_app_number] => 09740671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880449 [patent_doc_number] => 20010031736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity' [patent_app_type] => new [patent_app_number] => 09/837416 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2587 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031736.pdf [firstpage_image] =>[orig_patent_app_number] => 09837416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216713 [patent_doc_number] => 06706692 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => '6-deoxy erythromycin derivatives, method for preparing same and use as medicines' [patent_app_type] => B1 [patent_app_number] => 09/744320 [patent_app_country] => US [patent_app_date] => 2001-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2799 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706692.pdf [firstpage_image] =>[orig_patent_app_number] => 09744320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033376 [patent_doc_number] => 20020019353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals' [patent_app_type] => new [patent_app_number] => 09/829672 [patent_app_country] => US [patent_app_date] => 2001-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23920 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019353.pdf [firstpage_image] =>[orig_patent_app_number] => 09829672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560132 [patent_doc_number] => 06436906 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => '9-amino-14-membered macrolides derived from leucomycins' [patent_app_type] => B1 [patent_app_number] => 09/824318 [patent_app_country] => US [patent_app_date] => 2001-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11486 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 419 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436906.pdf [firstpage_image] =>[orig_patent_app_number] => 09824318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6987241 [patent_doc_number] => 20010036922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Method of treating a parasitic infection' [patent_app_type] => new [patent_app_number] => 09/823364 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3097 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036922.pdf [firstpage_image] =>[orig_patent_app_number] => 09823364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674822 [patent_doc_number] => 20030060425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Immune modulation method using steroid compounds' [patent_app_type] => new [patent_app_number] => 09/820483 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 165008 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060425.pdf [firstpage_image] =>[orig_patent_app_number] => 09820483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6886822 [patent_doc_number] => 20010020091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-06 [patent_title] => 'Corn fiber for the production of advanced chemicals and materials: arabinoxylan and arabinoxylan derivatives prepared therefrom' [patent_app_type] => new [patent_app_number] => 09/818209 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 45391 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20010020091.pdf [firstpage_image] =>[orig_patent_app_number] => 09818209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702246 [patent_doc_number] => 20030225126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Bactericidal antimicrobial methods and compositions for use in treating gram positive infections' [patent_app_type] => new [patent_app_number] => 09/816761 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18599 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225126.pdf [firstpage_image] =>[orig_patent_app_number] => 09816761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898923 [patent_doc_number] => 20010047088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Process for the preparation of 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin A derivatives from 9-deoxo-9 (Z)-hydroxyiminoerythromycin A' [patent_app_type] => new [patent_app_number] => 09/815389 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4131 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20010047088.pdf [firstpage_image] =>[orig_patent_app_number] => 09815389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874597 [patent_doc_number] => 20020049167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Azithromycin as a therapeutic agent for infections with leishmania parasites' [patent_app_type] => new [patent_app_number] => 09/813374 [patent_app_country] => US [patent_app_date] => 2001-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4081 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049167.pdf [firstpage_image] =>[orig_patent_app_number] => 09813374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348154 [patent_doc_number] => 06583164 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Antimycotic drug composition' [patent_app_type] => B1 [patent_app_number] => 09/787656 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25151 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583164.pdf [firstpage_image] =>[orig_patent_app_number] => 09787656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225318 [patent_doc_number] => 20020004486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Sustained-release compositions for parenteral administration' [patent_app_type] => new [patent_app_number] => 09/809525 [patent_app_country] => US [patent_app_date] => 2001-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2878 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004486.pdf [firstpage_image] =>[orig_patent_app_number] => 09809525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1421921 [patent_doc_number] => 06515116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Method of preparing form II crystals of clarithromycin' [patent_app_type] => B2 [patent_app_number] => 09/805831 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7891 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/515/06515116.pdf [firstpage_image] =>[orig_patent_app_number] => 09805831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1422221 [patent_doc_number] => 06506886 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Method of preparing form II crystals of clarithromycin' [patent_app_type] => B1 [patent_app_number] => 09/786636 [patent_app_country] => US [patent_app_date] => 2001-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1144 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506886.pdf [firstpage_image] =>[orig_patent_app_number] => 09786636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602971 [patent_doc_number] => 06433150 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Anthracycline analogues bearing latent alkylating substituents' [patent_app_type] => B1 [patent_app_number] => 09/796606 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 11023 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/433/06433150.pdf [firstpage_image] =>[orig_patent_app_number] => 09796606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347455 [patent_doc_number] => 06583120 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Erythromycin derivative with antibiotic activity' [patent_app_type] => B1 [patent_app_number] => 09/744245 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3385 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583120.pdf [firstpage_image] =>[orig_patent_app_number] => 09744245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589236 [patent_doc_number] => 06482801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-19 [patent_title] => '9a, 11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin' [patent_app_type] => B2 [patent_app_number] => 09/794381 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7086 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 453 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482801.pdf [firstpage_image] =>[orig_patent_app_number] => 09794381 [rel_patent_id] =>[rel_patent_doc_number] =>)